Insider · CIK 0001741850

KREHER NERISSA

Reports to the SEC for 4 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001741850

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-01	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.9K sh	$8.00	+$303K	37,910
2026-07-01	XERSXeris Biopharma Holdings, Inc.A Award	Director	AAward	+33.6K sh	—	—	33,582
2025-11-19	RZLTRezolute, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2025-11-19	RZLTRezolute, Inc.A Award	Director	AAward	+21K sh	—	—	58,576
2025-06-13	RZLTRezolute, Inc.P Purchase	Director	PPurchase	+3,076 sh	$3.25	+$9,997	37,576
2025-06-10	RZLTRezolute, Inc.A Award	Director	AAward	+9,000 sh	—	—	34,500
2025-06-10	RZLTRezolute, Inc. · Director Stock Options (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2025-02-16	RZLTRezolute, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-02-16	RZLTRezolute, Inc.A Award	Director	AAward	+25.5K sh	—	—	25,500
2024-01-23	RZLTRezolute, Inc. · Director Stock Options (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-09-06	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−21 sh	$14.00	−$294	40,037
2023-09-06	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−871 sh	$13.46	−$11.7K	40,058
2023-09-05	TRDAEntrada Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−401 sh	$14.46	−$5,799.463	40,929
2023-09-01	TRDAEntrada Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+14.2K sh	—	—	41,330
2023-09-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+21.5K sh	—	—	21,500
2023-08-04	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−6,898 sh	—	—	88,012
2023-08-04	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−6,898 sh	$14.14	−$97.5K	27,130
2023-08-04	TRDAEntrada Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+6,898 sh	$2.10	+$14.5K	34,028
2023-08-03	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−9,464 sh	—	—	94,910
2023-08-03	TRDAEntrada Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+9,464 sh	$2.10	+$19.9K	36,594
2023-08-03	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−9,464 sh	$14.74	−$140K	27,130
2023-08-02	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−9,280 sh	$15.09	−$140K	28,198
2023-08-02	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−68 sh	$16.82	−$1,143.76	27,130
2023-08-02	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10.3K sh	—	—	104,374
2023-08-02	TRDAEntrada Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10.3K sh	$2.10	+$21.7K	37,478
2023-08-02	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,000 sh	$16.01	−$16K	27,198
2023-03-02	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,477 sh	$10.49	−$15.5K	41,494
2023-03-02	TRDAEntrada Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−945 sh	$11.60	−$11K	42,971
2023-03-02	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−164 sh	$11.22	−$1,840.523	41,330
2023-03-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+21.5K sh	—	—	21,500
2023-03-01	TRDAEntrada Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+28.4K sh	—	—	43,916
2023-03-01	TRDAEntrada Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+14.2K sh	—	—	27,130
2023-03-01	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+43K sh	—	—	43,000
2022-12-30	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,200 sh	$13.45	−$69.9K	15,516
2022-10-26	TRDAEntrada Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,960 sh	$2.10	+$10.4K	25,676
2022-10-26	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−643 sh	$21.21	−$13.6K	25,033
2022-10-26	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,317 sh	$22.01	−$95K	20,716
2022-10-26	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,960 sh	—	—	114,722
2022-10-25	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−100 sh	$22.13	−$2,213	20,716
2022-10-25	TRDAEntrada Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,040 sh	$2.10	+$16.9K	28,756
2022-10-25	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,942 sh	$20.53	−$101K	23,814
2022-10-25	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,040 sh	—	—	119,682
2022-10-25	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,998 sh	$21.42	−$64.2K	20,816
2022-09-28	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−3,122 sh	—	—	16,032
2022-09-28	TRDAEntrada Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,122 sh	$2.10	+$6,556.2	23,838
2022-09-28	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,122 sh	$15.25	−$47.6K	20,716
2022-09-27	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,403 sh	$15.31	−$36.8K	20,716
2022-09-27	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,403 sh	—	—	19,154
2022-09-27	TRDAEntrada Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,403 sh	$2.10	+$5,046.3	23,119
2022-09-26	TRDAEntrada Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,768 sh	$15.22	−$42.1K	21,016

Recent filings

Accepted (ET)
Jul 24
KREHER NERISSA0001741850-26-000002
SEC(opens sec.gov)
Nov 214
KREHER NERISSA0000912282-25-001290
SEC(opens sec.gov)
Jun 234
KREHER NERISSA0000912282-25-000699
SEC(opens sec.gov)
Jun 134
KREHER NERISSA0000912282-25-000668
SEC(opens sec.gov)
Feb 194
KREHER NERISSA0000912282-25-000178
SEC(opens sec.gov)
Jan 254
KREHER NERISSA0000912282-24-000075
SEC(opens sec.gov)
Sep 64
KREHER NERISSA0001689375-23-000062
SEC(opens sec.gov)
Aug 44
KREHER NERISSA0001689375-23-000050
SEC(opens sec.gov)

Companies

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607